Viking Therapeutics, Inc. (VKTX) has a market capitalization of $4.1B and trades at $35.52. The 52-week range is 18.92-43.15.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.1, Earnings Per Share (EPS) of $-3.19.
The stock has a beta of 0.82, operates in the Healthcare sector.
